Namenda (memantine)
NAMENDA (memantine) – an orally active NMDA receptor antagonist commonly used to treat Alzheimer’s disease. Persistent activation of central nervous system N-methyl-D-aspartate (NMDA) receptors by the excitatory amino acid glutamate has been hypothesized to contribute to the symptomatology of Alzheimer’s disease. Memantine is postulated to exert its therapeutic effect through its action as a low […]